FDA approves Zanvastro, first disease-modifying treatment for Alexander diseasetranslating…

The FDA has approved Zanvastro, an antisense oligonucleotide treatment for pediatric and adult patients with Alexander disease, a rare, progressive and often fatal neurological disorder that can affect motor, cognitive, autonomic and gastrointestinal function.